We are monitoring the impact of COVID-19 on North America Preclinical In-vivo Imaging Market Get in touch with us for detailed analysis Know More
Share on

North America Preclinical In-vivo Imaging Market Research Report – Segmented By Modality, Reagent & By Country (US, Canada & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2022 to 2027)

Published: January, 2022
ID: 533
Pages: 140

North America Preclinical In-Vivo Imaging Market Size (2022 to 2027)

The Preclinical in-vivo imaging market in North America was estimated at USD 307.18 Million in 2022. It is projected to reach USD 390.18 Million by 2027, at a CAGR of 4.90% during the forecast period from 2022 to 2027.

The North America preclinical in-vivo imaging market is expected to be growing due to several factors, including technological advancements in the field of molecular imaging, rising market demand for non-invasive small animal imaging techniques, rising demand for non-invasive imaging techniques, and government support for research and development activities and an increase in the number of public-private initiatives and funding to support preclinical research. The demand for preclinical in-vivo imaging modalities is increasing in various industries, including research and development, drug discovery, cancer cell detection, and others. As a result of the growing number of clinical research organizations and pharmaceutical companies, in-vivo imaging technologies are being more widely used in preclinical research, propelling the market's growth.

Some of the primary factors restraining the growth of the Preclinical in-vivo Imaging market in the North American region include a rigorous regulatory framework that controls preclinical research, high product prices, and considerable installation and operational expenses associated with preclinical imaging modalities. Furthermore, standalone systems' technological and operational constraints pose a significant challenge for participants in the North American Preclinical in-vivo Imaging market.

This research report on the North America preclinical in-vivo imaging market has been segmented and sub-segmented into the following categories:

By Modality:

  • optical Imaging
  • Nuclear Imaging
  • Micro-MRI
  • Micro-CT
  • Micro-ultrasound
  • Photoacoustic
  • Magnetic Particle Imaging Systems

By Reagent:

  • optical Imaging Reagents
  • Nuclear Imaging Reagents
  • MRI Contrast Agents
  • Ultrasound Contrast Agents
  • CT Contrast Agents

By Country:

  • United States
  • Canada
  • Rest of North America

Regionally, North America holds the largest share of the global preclinical imaging market, while the U.S. has the maximum share in North America. The preclinical imaging market in North America is primarily driven by factors like a high volume of preclinical research in this region, easy availability and accessibility of resources, and rising government funding for research and innovation in Canada.

The expansion of the preclinical in-vivo imaging market in the United States is being accelerated by rising research and development funding and the availability of well-developed research infrastructure. Market participants are also collaborating with distributors to expand their product reach. For example, Aspect Imaging, a market leader in the design and development of compact magnetic resonance systems for preclinical, medical, and industrial applications announced in September 2017 that Quantum Analytics would be its exclusive US distributor for its Industrial product portfolio. A well-developed research infrastructure, the availability of trained personnel, a significant number of Preclinical projects, and more excellent adoption rates of technically advanced devices in the region are the primary drivers of the Preclinical In-vivo imaging market in North America. Furthermore, government activities in the region foster new clinical research and development projects.

The Canadian R&D tax credit scheme is an example of a government policy promoting the country's R&D activities. The Preclinical in-vivo imaging market benefits from government support in the form of funding and tax incentives. In light of all considerations, North America is expected to maintain its supremacy for the duration of the forecast period.

KEY MARKET PLAYERS:

Companies playing a dominant role in the North America Preclinical in-vivo imaging market profiled in this report are Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Modality                

                                5.1.1 Optical imaging      

                                                5.1.1.1 Bioluminescence/fluorescence imaging systems

                                                5.1.1.2 Standalone fluorescence imaging systems

                                                5.1.1.3 Optical + X-ray/optical + CT imaging systems

                                5.1.2 Nuclear imaging    

                                                5.1.2.1 Micro-PET systems (standalone PET, PET/CT, and PET/MRI)

                                                5.1.2.2 Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)

                                                5.1.2.3 Tri-modality (PET/SPECT/CT) imaging systems

                                5.1.3 Micro-MRI               

                                5.1.4 Micro-CT  

                                5.1.5 Micro-ultrasound 

                                5.1.6 Photoacoustic        

                                5.1.7 Magnetic particle imaging systems               

                5.2 By Reagent                 

                                5.2.1 Optical imaging reagents   

                                                5.2.1.1 Bioluminescent reagents

                                                5.2.1.2 Fluorescent imaging reagents

                                5.2.2 Nuclear imaging reagents 

                                                5.2.2.1 Preclinical PET tracers

                                                5.2.2.2 Preclinical SPECT probes

                                5.2.3 MRI contrast agents            

                                5.2.4 Ultrasound contrast agents             

                                5.2.5 CT contrast agents               

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 United States            

                                6.3 Canada         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Aspect Imaging                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Biospace Lab S.A.                     

                8.3 Bruker Corporation                 

                8.4 LI-COR Biosciences                  

                8.5 Mediso Ltd.                

                8.6 MILabs B.V.                

                8.7 MR Solutions Ltd                      

                8.8 PerkinElmer               

                8.9 TriFoil Imaging                           

                8.10 FUJIFILM VisualSonics, Inc.                                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Preclinical in-vivo imaging Market By Region, From 2022 - 2027 (USD Million)
  2. North America Preclinical in-vivo imaging Market By Modality, From 2022 - 2027 (USD Million)
  3. North America Preclinical Optical imaging Market By Region, From 2022 - 2027 (USD Million)
  4. North America Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2022 - 2027 (USD Million)
  5. North America Preclinical Standalone fluorescence imaging systems Market By Region, From 2022 - 2027 (USD Million)
  6. North America Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2022 - 2027 (USD Million)
  7. North America Preclinical Nuclear imaging Market By Region, From 2022 - 2027 (USD Million)
  8. North America Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2022 - 2027 (USD Million)
  9. North America Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2022 - 2027 (USD Million)
  10. North America Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2022 - 2027 (USD Million)
  11. North America Preclinical Micro-MRI Market By Region, From 2022 - 2027 (USD Million)
  12. North America Preclinical Micro-CT Market By Region, From 2022 - 2027 (USD Million)
  13. North America Preclinical Micro-ultrasound Market By Region, From 2022 - 2027 (USD Million)
  14. North America Preclinical Photoacoustic Market By Region, From 2022 - 2027 (USD Million)
  15. North America Preclinical Magnetic particle imaging systems Market By Region, From 2022 - 2027 (USD Million)
  16. North America Preclinical in-vivo imaging Market By Reagent, From 2022 - 2027 (USD Million)
  17. North America Preclinical Optical imaging reagents Market By Region, From 2022 - 2027 (USD Million)
  18. North America Preclinical Bioluminescent reagents Market By Region, From 2022 - 2027 (USD Million)
  19. North America Preclinical Fluorescent imaging reagents Market By Region, From 2022 - 2027 (USD Million)
  20. North America Preclinical Nuclear imaging reagents Market By Region, From 2022 - 2027 (USD Million)
  21. North America Preclinical PET tracers Market By Region, From 2022 - 2027 (USD Million)
  22. North America Preclinical SPECT probes Market By Region, From 2022 - 2027 (USD Million)
  23. North America Preclinical MRI contrast agents Market By Region, From 2022 - 2027 (USD Million)
  24. North America Preclinical Ultrasound contrast agents Market By Region, From 2022 - 2027 (USD Million)
  25. North America Preclinical CT contrast agents Market By Region, From 2022 - 2027 (USD Million)
  26. United States Preclinical in-vivo imaging Market By Modality, From 2022 - 2027 (USD Million)
  27. United States Preclinical in-vivo imaging Market By Reagent, From 2022 - 2027 (USD Million)
  28. United States Preclinical Optical Imaging Market By Optical imaging, From 2022 - 2027 (USD Million)
  29. United States Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2022 - 2027 (USD Million)
  30. United States Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2022 - 2027 (USD Million)
  31. United States Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2022 - 2027 (USD Million)
  32. Canada Preclinical in-vivo imaging Market By Modality, From 2022 - 2027 (USD Million)
  33. Canada Preclinical in-vivo imaging Market By Reagent, From 2022 - 2027 (USD Million)
  34. Canada Preclinical Optical Imaging Market By Optical imaging, From 2022 - 2027 (USD Million)
  35. Canada Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2022 - 2027 (USD Million)
  36. Canada Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2022 - 2027 (USD Million)
  37. Canada Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample